Human Erythropoietin Injection

Approx. Rs 2,000 / PieceGet Latest Price

Product BrochureProduct Details:

Renocrit 4000 IU is a sterile, single-dose injection containing recombinant human erythropoietin (EPO) used to treat anemia associated with chronic kidney disease (CKD) or chemotherapy. Stimulates red blood cell production to improve oxygen delivery. Administer subcutaneously or intravenously as prescribed by a healthcare provider. Monitor hemoglobin levels regularly to avoid polycythemia. Common side effects may include hypertension or headache. Contraindicated in uncontrolled hypertension or pure red cell aplasia. Store refrigerated (2–8°C); protect from light. Do not shake. Keep out of reach of children. Prescription required.

Approx. Rs 2,000 / PieceGet Latest Price

Product BrochureProduct Details:

Renocel Recombinant Human Erythropoietin Alfa Injection IP 4000 IU stimulates red blood cell production to treat anemia caused by chronic kidney disease, chemotherapy, or other conditions. This injectable therapy enhances oxygen delivery and energy levels. Use under strict medical supervision for safe and effective anemia management.

Approx. Rs 1,056 / PieceGet Latest Price

Product BrochureProduct Details:

Relipoietin Erythropoietin Injection IP 4000 IU stimulates red blood cell production to treat anemia caused by chronic kidney disease, chemotherapy, or other medical conditions. This injectable therapy helps improve oxygen delivery and energy levels. Use under medical supervision to ensure safe and effective anemia management.

Approx. Rs 1,000 / PieceGet Latest Price

Product BrochureProduct Details:

Relipoietin 10000 IU Erythropoietin Injection IP is a synthetic version of the naturally occurring erythropoietin (EPO) hormone, which is primarily produced by the kidneys and plays a critical role in the production of red blood cells in the bone marrow. Relipoietin is used to treat anemia (low red blood cell count), especially in patients with chronic kidney disease (CKD), those undergoing chemotherapy, or individuals with certain other conditions that result in low erythropoietin levels.